GlobeNewswire Inc.··NaNRx Pharmaceuticals Appoints First Chief Commercial Officer Ahead of Ketamine FDA Approvals
NRx Pharmaceuticals names Glenn Tyson as inaugural Chief Commercial Officer, bolstering leadership ahead of anticipated FDA approvals for ketamine products.
NRXPNRXPWBreakthrough Therapy DesignationFast Track designation